Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients

Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients

(2018) Dong Wook Jekarl et al.   Annals of Laboratory Medicine

Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients

(2016) D. Lin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C

(2016) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

(2016) Xia Zou et al.   LIVER INTERNATIONAL

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation

(2016) Hiroki Nishikawa et al.   MEDICINE

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus

(2016) Ja Yoon Heo et al.   MEDICINE

Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C

(2015) K. Ura et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Noninvasive Assessment of Liver Fibrosis

(2015) Laurent Castera   DIGESTIVE DISEASES

AASLD guidelines for treatment of chronic hepatitis B

(2015) Norah A. Terrault et al.   HEPATOLOGY

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

(2015) S. K. Sarin et al.   Hepatology International

Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

(2015) Hidenori Toyoda et al.   LIVER INTERNATIONAL

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response

(2015) Ryu Sasaki et al.   PLoS One

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis

(2014) Guangqin Xiao et al.   HEPATOLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

(2012) Tetsuya Hosaka et al.   HEPATOLOGY

Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update

(2011) Giacomo Germani et al.   SEMINARS IN LIVER DISEASE

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis

(2010) Zhong-Hua Lin et al.   HEPATOLOGY

Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies

(2010) Robert P. Myers et al.   LIVER INTERNATIONAL

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

(2009) Yun-Fan Liaw   LIVER INTERNATIONAL